• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A mathematical model of breast and ovarian cancer treated with paclitaxel.

作者信息

Panetta J C

机构信息

Mathematics Program, Penn State Erie, Behrend College 16563, USA.

出版信息

Math Biosci. 1997 Dec;146(2):89-113. doi: 10.1016/s0025-5564(97)00077-1.

DOI:10.1016/s0025-5564(97)00077-1
PMID:9348741
Abstract

A mathematical model that describes the effects of cell-cycle-specific drugs on cancer and normal tissue is developed. The model takes into account the proliferating cells, which are sensitive to the treatment, and the quiescent cells, which are resistant to the treatment. With the use of information from the medical literature, model parameters are estimated for breast and ovarian cancer as well as for bone marrow. Then, with the use of the model and the estimated parameters, some acceptable treatment strategies are discussed in terms of treatment period, drug-infusion time, and proliferative fraction of cancer mass. Finally, these results are compared with current clinical practices for treatment with Taxol, and possible improvements on current treatment strategies are suggested.

摘要

相似文献

1
A mathematical model of breast and ovarian cancer treated with paclitaxel.
Math Biosci. 1997 Dec;146(2):89-113. doi: 10.1016/s0025-5564(97)00077-1.
2
[Taxol (paclitaxel) as second-line therapy in breast and ovarian cancer].
Harefuah. 1998 Apr 15;134(8):605-8, 671.
3
Intrapleural paclitaxel for malignant pleural effusion from ovarian and breast cancer: a phase II study with pharmacokinetic analysis.紫杉醇胸腔内注射治疗卵巢癌和乳腺癌所致恶性胸腔积液:一项药代动力学分析的 II 期研究。
Cancer Chemother Pharmacol. 2012 Mar;69(3):781-7. doi: 10.1007/s00280-011-1765-y. Epub 2011 Oct 29.
4
Paclitaxel. An update of its use in the treatment of metastatic breast cancer and ovarian and other gynaecological cancers.紫杉醇。其在转移性乳腺癌、卵巢癌及其他妇科癌症治疗中应用的最新进展。
Drugs Aging. 1998 Apr;12(4):305-34. doi: 10.2165/00002512-199812040-00005.
5
[Taxol].[紫杉醇]
Zentralbl Gynakol. 1996;118(10):580.
6
Phase I study with a weekly 1 h infusion of paclitaxel in heavily pretreated patients with metastatic breast and ovarian cancer.
Eur J Cancer. 1996 Mar;32A(3):547-9. doi: 10.1016/0959-8049(95)00641-9.
7
[Paclitaxel].[紫杉醇]
Rev Med Univ Navarra. 1996 Jul-Sep;40(3):43-51.
8
A feasibility study of 1-h paclitaxel infusion in patients with solid tumors.
Cancer Chemother Pharmacol. 1997;40(4):353-7. doi: 10.1007/s002800050669.
9
Paclitaxel and docetaxel in breast and ovarian cancer.紫杉醇和多西他赛在乳腺癌和卵巢癌中的应用
Drug Ther Bull. 1997 Jun;35(6):43-6.
10
Paclitaxel premedication regimens.紫杉醇预处理方案。
J Natl Cancer Inst. 1996 Apr 3;88(7):463-5. doi: 10.1093/jnci/88.7.463.

引用本文的文献

1
Negligible Long-Term Impact of Nonlinear Growth Dynamics on Heterogeneity in Models of Cancer Cell Populations.非线性生长动力学对癌细胞群体模型中异质性的长期影响可忽略不计。
Bull Math Biol. 2025 Jan 3;87(2):18. doi: 10.1007/s11538-024-01395-w.
2
Machine Learning Methods for Precision Dosing in Anticancer Drug Therapy: A Scoping Review.机器学习方法在抗癌药物治疗中的精准剂量学:范围综述。
Clin Pharmacokinet. 2024 Sep;63(9):1221-1237. doi: 10.1007/s40262-024-01409-9. Epub 2024 Aug 17.
3
Applications of Machine Learning (ML) and Mathematical Modeling (MM) in Healthcare with Special Focus on Cancer Prognosis and Anticancer Therapy: Current Status and Challenges.
机器学习(ML)和数学建模(MM)在医疗保健中的应用,特别关注癌症预后和抗癌治疗:现状与挑战
Pharmaceutics. 2024 Feb 9;16(2):260. doi: 10.3390/pharmaceutics16020260.
4
Reinforcement learning derived chemotherapeutic schedules for robust patient-specific therapy.强化学习衍生的化疗方案,用于稳健的患者特异性治疗。
Sci Rep. 2021 Sep 9;11(1):17882. doi: 10.1038/s41598-021-97028-6.
5
Virtual clinical trials identify effective combination therapies in ovarian cancer.虚拟临床试验确定卵巢癌的有效联合疗法。
Sci Rep. 2019 Dec 10;9(1):18678. doi: 10.1038/s41598-019-55068-z.
6
A multi-state model of chemoresistance to characterize phenotypic dynamics in breast cancer.一种多状态模型用于研究乳腺癌的化疗耐药性,以描述其表型动力学特征。
Sci Rep. 2018 Aug 13;8(1):12058. doi: 10.1038/s41598-018-30467-w.
7
Mathematical models of breast and ovarian cancers.乳腺癌和卵巢癌的数学模型。
Wiley Interdiscip Rev Syst Biol Med. 2016 Jul;8(4):337-62. doi: 10.1002/wsbm.1343. Epub 2016 Jun 3.
8
Modeling the Dynamics of High-Grade Serous Ovarian Cancer Progression for Transvaginal Ultrasound-Based Screening and Early Detection.基于经阴道超声的高级别浆液性卵巢癌进展动态建模用于筛查和早期检测
PLoS One. 2016 Jun 3;11(6):e0156661. doi: 10.1371/journal.pone.0156661. eCollection 2016.
9
Novel phase I study combining G1 phase, S phase, and G2/M phase cell cycle inhibitors in patients with advanced malignancies.一项针对晚期恶性肿瘤患者联合G1期、S期和G2/M期细胞周期抑制剂的新型I期研究。
Cell Cycle. 2015;14(21):3434-40. doi: 10.1080/15384101.2015.1090065.
10
A mechanistic tumor penetration model to guide antibody drug conjugate design.一种用于指导抗体药物偶联物设计的机制性肿瘤渗透模型。
PLoS One. 2015 Mar 18;10(3):e0118977. doi: 10.1371/journal.pone.0118977. eCollection 2015.